Ebola outbreak tops 10,000 cases as health chief issues urgent global warning
The Daily Mail reports on an urgent warning issued by Dr. Jean Kaseya, Director-General of the Africa Centers for Disease Control and Prevention (Africa CDC). He has urged countries outside Africa to strengthen their preparedness as the Ebola outbreak surpasses 10,000 confirmed cases. However, European health authorities currently assess the infection risk for the general EU/EEA population as very low.
Dr Kaseya drew an analogy to COVID-19. He reminded world leaders that many countries initially assumed there was “zero risk” before the virus gripped the entire planet. He urged nations outside Africa, including the UK, to strengthen their preparedness and capacity to identify and treat cases. Moreover, Africa CDC has reported that the outbreak has affected three African regions: Central, Eastern, and Western Africa. However, imported cases do not necessarily indicate sustained local transmission.
Incubation Period and International Travel
According to WHO, Ebola’s incubation period ranges from two to 21 days. Consequently, an infected person may travel internationally before symptoms develop and without realizing they are infected. However, people do not transmit the disease before symptoms begin.
This incubation period can complicate symptom-based screening because some infected travelers may appear well upon arrival. Therefore, identifying potential exposure and monitoring known contacts remain important parts of the public-health response.
Imported cases and medical evacuations have already brought patients to Europe. France recorded an imported case involving a healthcare worker returning from the Democratic Republic of the Congo (DRC). More recently, a woman diagnosed with Ebola in Nigeria was medically evacuated to Geneva on October 26. She had previously travelled from Uganda, and investigators were still examining where she had been exposed.
The current outbreak is caused by Bundibugyo virus, one of the viruses that cause Ebola disease. WHO figures covering data through October 26 indicate a case-fatality ratio of approximately 48% among confirmed cases.
Unlike Ebola disease caused by Zaire virus, Bundibugyo virus disease currently has no licensed vaccine or specific approved treatment. Initial symptoms include fever, headache, and muscle pain. The illness may then progress to vomiting, diarrhea, dehydration, and impaired kidney or liver function. Some patients also develop bleeding or life-threatening complications.
[SOURCE]
